Cohance Lifesciences shares decline over 2% after Hyderabad unit gets USFDA Warning Letter

Cohance Lifesciences said it had earlier informed the stock exchanges that the facility was classified as Official Action Indicated (OAI) and the warning letter is in continuation of the same.

Leave a Reply

Your email address will not be published. Required fields are marked *